Editorial Board

The Inadequate War on Alzheimer's

Research spending is far too low for such a common, costly disease.


Source: BSIP/UIG via Getty Images

The fight against Alzheimer's disease tallied a small victory last week, when two new drugs were found that possibly slow its relentless attack on brain cells. But the search for a cure isn't moving nearly quickly enough.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.